Scaling up and scaling out your allogeneic and autologous cell therapies
January 25th at 15:00pm GMT
Challenges This Webinar Will Address:
- Manufacturing Customization
- Scalability Solutions
- Regulatory Compliance
FamiCord operates multiple state-of-the-art Good Manufacturing Practice production facilities. As a leading cell therapy manufacturer our knowledge, experience and flexibility allow us to be your ideal manufacturing partner for clinical and pre-clinical projects alike.
We have proven experience in delivering GMP grade products from a wide variety of cell types isolated from various starting materials, with manufacturing processes which are fully customizable and scalable to support your needs.
On-site our development and production teams work closely to ensure a smooth transition of your cell therapy product from development through to clinical use. Each facility is equipped with it's very own R&D and production teams to offer full-service capabilities.
FamiCords global network allows us to scale-up and scale-out your allogeneic and autologous cell therapies from the most suitable facility. Our state-of-the-art GMP facilities are EMA compliant offering confidence in manufacturing.
Our Manufacturing flexibility is what we pride ourselves on. We understand manufacturing processes are not one size fits all, our processes are built with this in mind to allow us to fully customize the methods, scale and QC testing to suit our clients requirements.
Speakers
Tomasz Baran
Chief Commercial Officer
Key Takeaways
- Scalability Strategies
- Customizable Manufacturing
- Seamless Transition
- Global Scaling
- Regulatory Compliance